Amplification of oncogenes in human cancer cells

BioEssays

Volumn 20, Issue 6, 1998, Pages 473-479

  Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; GENE AMPLIFICATION; GENE MUTATION; ONCOGENE; PROTO ONCOGENE;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; NEOPLASMS; NEUROBLASTOMA; ONCOGENES; SARCOMA;

EID: 0032104542     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199806)20:6<473::AID-BIES5>3.0.CO;2-N     Document Type: Review

References (75)

1. Schimke RT (1982) Gene Amplification. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
2. Schwab M (1985) Amplification of N-myc in human neuroblastomas. TIG 10:271-275.
3. Alitalo K, Schwab M (1986) Oncogene amplification in tumor cells. Adv Cancer Res 47:235-281.
4. Schwab M, Amler LC (1990) Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer. Genes Chromosom Cancer 1:181-193.
5. Guan X-Y, et al. (1994) Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nature enet. 8:155-161.
6. Kallioniemi A, et al. (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 258:818-821.
7. Joos S, et al. (1993) Detection of amplified genomic sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 90:584-589.
8. Visakorpi T, et al. (1995) In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nature Genet 9:401-406.
9. Amler LC, Schwab M (1989) Amplified MYCN in human neuroblastoma cells is often arranged as clustered tandem repeats of differently recombined DNA. Mol Cell Biol 9:4903-4913.
10. Szepetowski P, Perucca-Lostanlen D, Gaudray P (1993) Mapping genes according to their amplification status in tumor cells: Contribution of the map of 11q13. Genomics 16:745-750.
11. Schwab M, Corvi R, Amler LC (1995) N-MYC oncogene amplification: A consequence of genomic instability in human neuroblastoma. Neuroscientist 1:277-285.
12. Gaudray P, et al. (1992) DNA amplification at 11q13 in human cancer: from complexity to perplexity. Mutat Res 276:317-328.
13. Khatib ZA, et al. (1993) Coamplification of the CDK4 gene with MDM2 and GL/ in human sarcomas. Cancer Res 53:5535-5541.
14. Corvi R, et al. (1995) Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene 10:1081-1086.
15. Kohl N, et al. (1983) Transposition and amplification of oncogene related sequence in human neuroblastomas. Cell 35:359-367.
16. Schwab M, et al. (1983) Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor. Nature 305:245-248.
17. Schwab M (1993) Amplification of N-myc as a prognostic marker for patients with neuroblastoma. Semin Cancer Biol 4:13-18.
18. Corvi R, et al. (1994) MYCN is retained in single copy at chromosome 2 band p23-24 during amplification in human neuroblastoma cells. Proc Natl Acad Sci USA 91:5523-5527.
19. Corvi R, Savelyeva L, Schwab M (1995) Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 55:3471-3474.
20. Amler LC, Schürmann J, Schwab M (1996) The DDX1 gene maps within 400 kbp 5′ to MYCN and is frequently coamplified in human neuroblastomas. Genes Chromosom Cancer 15:134-137.
21. Godbout S, Squire J (1993) Amplification of a DEAD box protein in retinoblastoma cell lines. Proc Natl Acad Sci USA 90:7578-7592.
22. Lutz W, Schwab M (1997) In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells. Oncogene 15:303-315.
23. Schwab M, et al. (1984) Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 81:4940-4944.
24. Ramsay G, et al. (1986) Human proto-oncogene N-myc encodes nuclear proteins that bind DNA. Mol Cell Biol 6:4450-4457.
25. Wenzel A, et al. (1991) The mycN oncoprotein is associated in vivo with the phosphoprotein Max (p21/22) in human neuroblastoma cells. EMBO J 10:3703-3712.
26. Blackwood EM, Eisenmann RN (1991) max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with myc. Science 251:1211-1217.
27. Zervos A, Gyuris J, Brent R (1993) Mxi, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72:21-40.
28. Ayer DE, Kretzner L, Eisenman RN (1993) Mad: A heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72:1-20
29. Wenzel A, Schwab M (1995) The mycN/max protein complex in neuroblastoma. Eur J Cancer 31A:516-519.
30. Brodeur GM, et al. (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124.
31. Bartram CR, Berthold F (1987) Amplification and expression of the N-myc gene in neuroblastoma. Eur J Pediatr 146:162-165.
32. Berthold F (1990) Overview: biology of neuroblastoma. In Pochedly C (ed): Neuroblastoma: Tumor Biology and Therapy. Boca Raton, FL: CRC Press, p 1-27.
33. Seeger RC, et al. (1985) Association of multiple copies of the MYCN oncogene with rapid progression of neuroblastoma. N Enql Med 313:1111-1116.
34. Rubie H, et al. (1997) N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: Results of the French NBL 90 study. Neuroblastoma Study Group of the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 15:1171-1182.
35. Schwab M, Joshi V (1997) Neuroblastic tumors of the adrenal gland and sympathetic nervous system. In Kleihues P, Cavenee W (eds): Pathology and Genetics of Tumors of the Nervous System. Lyons: IARC Monographs, pp 117-123.
36. Schechter AL, et al. (1985) The neu gene: An erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229:976-978.
37. Coussens L, et al. (1985) Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science 230:1132-1139.
38. Semba K, et al. (1985) A v-erbB-related proto-oncogene c-erbB-2, is distinct from the c-erbB-1 epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci USA 82:6497-6501.
39. King CR, Kraus MH, Aaronson S (1985) Amplification of a novel erbB-related gene in a human mammary carcinoma. Science 229:974-976.
40. Slamon DJ, et al. (1987) Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
41. Slamon DJ, et al. (1989) Studies of the Her/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
42. Vijver van de M, et al. (1987) Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene. Mol Cell Biol 7:2019-2023.
43. Lönn U, et al. (1996) Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis. Breast Cancer Res Treat 39:213-220.
44. Vijver van der MJ (1993) Molecular genetic changes in human breast cancer. Adv Cancer Res 61:25-56.
45. Liderau R, et al. (1988) Amplification of the INT2 gene in primary human breast tumors. Oncogene Res 2:285-291.
46. Lammie GA, Peters G (1991) Chromosome 11q13 abnormaliteis in human cancer. Cancer Cells 3:413-420.
47. Gaudray P, et al. (1992) DNA amplification at 11q13 in human cancer from complexity to perplexity. Mutat Res 3:317-328.
48. Roelofs H, et al. (1993) Amplification of the 11q13 region in human carcinoma cell lines: A mechanistic view. Genes Chromosom Cancer 7:74-84.
49. Theillet C, et al. (1990) BCL-1 participates in the 11q13 amplification found in breast cancer. Oncogene 5:147-149.
50. Lammie GA, et al. (1991) D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene 6:439-444.
51. Bringuier PP, et al. (1996) Expression of cyclin D1 and EMS1 in bladder tumours: relationship with chromosome 11q13 amplification. Oncogene 12:1747-1753.
52. Hunter T, Pines J (1991) Cyclins and cancer. Cell 66:1081-1074.
53. Proctor AJ, et al. (1991) Amplification at chromosome 11q13 in transitional cell tumours of the bladder. Oncogene 6:789-795.
54. Szepetowski P, et al. (1992) Amplification of 11q13 DNA sequences in human breast cancer: D11S97 identifies a region tightly linked to BCL1 which can be amplified separately. Oncogene 7:751-755.
55. Lammie GA, Peters G (1991) Chromosome 11q13 abnormalities in human cancer. Cancer Cell 3:413-420.
56. Kinzler KW, et al. (1987) Identification of an amplified, highly expressed gene in human glioma. Science 236:70-73.
57. Ruppert JM, Vogelstein B, Kinzler KW (1990) The zinc finger protein GLI transforms primary cells in cooperation with adenovirus E1A. Mol Cell Biol 11:1724-1728.
58. Oliner JD, et al. (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83.
59. Reifenberger G, et al. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739.
60. Jankowski SA, et al. (1994) SAS, a gene amplified in human sarcomas, encodes a new member of the transmembrane 4 superfamily of proteins. Oncogene 9:1205-1211.
61. Khatib ZA, et al. (1993) Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomams. Cancer Res 53:5535-5541.
62. Reifenberger G, et al. (1994) Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: Preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res 54:4299-4303.
63. Berner J-M, et al. (1997) HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene 14:2935-2941.
64. Schimke RT (1984) Gene amplification in cultured animal cells. Cell 37:705-713.
65. Stark GR, et al. (1989) Recent progress in understanding mechanisms of mammalian DNA amplification. Cell 57:901-908.
66. Schimke RT (1992) Gene amplification; What are we learning? Mutat Res 276:145-149.
67. Yin Y, et al. (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.
68. Reifenberger G, et al. (1993) Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 53:2736-2739.
69. Coquelle A, et al. (1997) Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
70. Smith KA, et al. (1990) Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63:1219-1227.
71. Smith KA, et al. (1992) Fusions near telomeres occur very early in the amplification of CAD genes in Syrian hamster cells. Proc Natl Acad Sci USA 89:5427-5431.
72. Toledo F, et al. (1992) Coamplified markers alternate in megabase long chromosomal inverted repeats and cluster independently in interphase nuclei at early steps of mammalian gene amplification. EMBO J 11:2665-2673.
73. Roelofs H, et al. (1992) Gene amplification in human cells may involve interchromosomal transposition and persistence of the original DNA region. New Biol 4:75-86.
74. Roelofs H, et al. (1992) Gene amplification in a human osteosarcoma cell line results in the persistence of the original chromosome and the formation of translocation chromosomes. Mutat Res 276:241-259.
75. Hyrien O, et al. (1988) The multicopy appearance of a large inverted duplication and the sequence at the inversion joint suggests a new model for gene amplification. EMBO J 7:407-117.